NCT03540251 is a NA clinical trial of Auricular Points Sticking in Breast Cancer, sponsored by Longhua Hospital.

Who is sponsoring NCT03540251?

NCT03540251 is sponsored by Longhua Hospital.

What drugs are being tested in NCT03540251?

Interventions in NCT03540251: Auricular Points Sticking.

What condition does NCT03540251 study?

NCT03540251 studies Breast Cancer, Hormonal Therapy, Hot Flashes, Acupuncture.

Is NCT03540251 still recruiting?

NCT03540251 is currently status unknown. Last updated 5 March 2019.

Last reviewed 2019-03-05 · How we verify

NCT03540251

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Clinical Study on Auricular Points Sticking Plus Chinese Medication for Hot Flashes in Breast Cancer Women

Status unknown NA Last updated 5 March 2019

What this trial tests

NA trial testing Auricular Points Sticking in Breast Cancer in 92 participants. Status unknown.

Timeline

4 January 2019

Primary endpoint
1 October 2019

1 December 2019

Quick facts

Lead sponsor	Longhua Hospital
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	supportive care
Enrollment	92
Start date	4 January 2019
Primary completion	1 October 2019
Estimated completion	1 December 2019
Sites	1 location across China

Drugs / interventions tested

Auricular Points Sticking

Conditions studied

Breast Cancer — all drugs for Breast Cancer →
Hormonal Therapy — all drugs for Hormonal Therapy →
Hot Flashes — all drugs for Hot Flashes →
Acupuncture — all drugs for Acupuncture →

Sponsor

Longhua Hospital

Who can join

Adults 30 to 55, female only, with Breast Cancer or Hormonal Therapy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Object:The aim of this study was to investigate the effectiveness of sticking and massaging auricular points for the management of hot flashes in postoperative breast cancer patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Breast Cancer

Currently open trials in the same condition.

NCT06148038 — CBD for Breast Cancer Primary Tumors · Phase 1 · recruiting
NCT07405801 — A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus R · Phase 2 · recruiting
NCT07285993 — Detection and Outcomes in Metastatic Invasive Lobular Breast Cancer Through Novel F-18 FAP PET · Phase 2 · recruiting
NCT07510698 — Same-Day Awake Mastectomy With Immediate Breast Reconstruction for Patients With Breast Cancer · NA · recruiting
NCT06768931 — Biolosion Combined Standard Neoadjuvant Therapy to Treat Triple-negative Breast Cancer · Phase 2 · recruiting

Other Longhua Hospital trials

Trials by the same sponsor.

NCT07478328 — Chaigui Longmu Ejiao Paste for Ischemic Heart Disease · Phase 2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03540251 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Longhua Hospital
Last refreshed: 5 March 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03540251.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing